Global Conference 2015

For all their many differences, Washington pundits and politicians frequently find common ground in the search for better therapies for our most devastating diseases. A rare bright spot of comity and bipartisanship, this shared interest in maintaining U.S. leadership in medical innovation presents several opportunities in 2015. From the 21st Century Cures legislation in Congress to the president's Precision Medicine Initiative to the FDA's next round of user fee negotiations, legislative and regulatory calendars are filling up with chances to advance science and help patients. Will 2015 bring the policy fixes needed to lower drug costs and increase patient input in the healthcare system? What can patients expect from Washington in the months ahead?


Margaret Anderson

Executive Director, FasterCures, a Center of the Milken Institute


Joe Barton

U.S. Congressman, Texas

Francis Collins

Director, National Institutes of Health

Robert Hugin

Chairman and CEO, Celgene

Michael Milken

Chairman, Milken Institute

Sara Radcliffe

President and CEO, California Life Sciences Association

Return to Program Detail